Graham to Trump: Make Iran ‘Feel Pain’ ‘Hit a

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
138
Graham to Trump: Make Iran ‘Feel Pain’
‘Hit a Refinery, Sink Their Navy’ < >

On Friday’s broadcast of “The Hugh Hewitt Show,” Sen. Lindsey Graham (R-SC) suggested President Donald Trump take an aggressive approach in responding to Iran’s saber-rattling in the Persian Gulf.

Among the actions the South Carolina Republican U.S. Senator included sinking the Iranian Navy and attacking one of Iran’s refineries, which he said would send a message to Iran not to interfere with the shipping lanes in the Persian Gulf.

HEWITT: Let’s turn to Iran. Earlier this morning, moments ago, the President of the United States said, “Iran did it;” the mine that didn’t explode “Had Iran written all over it.” He didn’t say what he is going to do, what do you think he ought to do about attacks on Gulf shipping Lindsey Graham?

GRAHAM: Make sure that the Iranians will never do it again because it hurt too much. If he doesn’t send a clear, unequivocal signal with pain attached, they will keep doing it. They are testing him. The president got out of the agreement. He’s put sanctions on Iran. He’s breaking the back of the Iranian government economically, they are pushing back, they are testing his will. One of the great minds of our time, General Keane, said there are a couple of options. One is, start sending naval escorts for commercial shipping in the Straights of Hormuz, that’s one thing to do —I don’t know how sustainable that is— the other thing is just basically sink their navy. Now, put them on notice, start escorting ships, and if there is another attack on commercial shipping in the Straights of Hormuz, just sink all these fast boats, just sink their navy.

HEWITT: That’s what President Reagan did in 1988, with Operation Praying Mantis. I’d like to hear Lindsey Graham’s assessment of this: They have a couple of major refinery complexes, maybe only two. They are attacking oil. Ought we to attack their refinery complexes because if you want to talk about bringing that country to a halt, that’s the way to do it.

GRAHAM: Well, this is why I like your show. You put options on the table that really hurt. The bottom line really here is that they are pushing back on multiple fronts now against President Trump —rocket man is still shooting rockets, Maduro is still in power, the Iranians are attacking ships in the Strait of Hormuz. I like the foreign policy of President Trump. He’s been the anti-Obama. But he’s got to get Iran put back in a box. This is a time of testing. They have hit four ships. They have attacked land-based pipelines, they haven’t felt anything yet, so if I were the president, attacking a refinery or sinking their navy would be an unequivocal signal: “I don’t want a war with Iran, but I don’t want Iran disrupting international navigation and freedom of the seas, and continue to be, you know, wrecking havoc, so, he’s got some options in the table.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rutter Mills Expands Turkey Giveaway to Two Cities

Updated Category News Views 78

An Extra Helping of Community Spirit Rutter Mills is back on the scene again this Thanksgiving, slinging out a thousand turkeys to show their appreciation for the community they’ve called home since 1959. This initiative is the second iteration of their Turkey Drop, an event that's set to become a cherished tradition for years to come. Last year's event only teased the...

Continue Reading
James Hardie Joins S&P MidCap 400; Roku Acquired

Updated Category News Views 97

A Shift in the MidCap 400: What's Up? Well, wouldn’t you know it, James Hardie Industries is making waves as it steps into the S&P MidCap 400. This move happens because Fox Corp. has nabbed Roku in a deal worthy of some popcorn. Come November 11, when the trading floor wakes up, James Hardie will be in and Roku will be out. Pretty neat switcheroo if you ask me. Inside...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 185

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 76

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Koppers Faces Investigation: Investors Cautious Amid Probe

Updated Category News Views 194

Deep Dive: Koppers' Financial Turmoil When a company throws a financial party, you don't expect the hangover to come in the form of an investigation notice. That’s what’s brewing over at Koppers Holdings Inc., leading many seasoned investors to take a hard, scrutinizing look at the books. The latest buzz? An inquiry into whether the company gave its investors the full...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 115

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Pinterest Faces Legal Probe: Investor Concerns Rise

Updated Category News Views 95

Legal Storms Gather on Pinterest's Horizon I remember a time when Pinterest was the darling of Wall Street, but here we are, staring at an investigation that's got more layers than an onion. On November 6, 2026, news broke that Kahn Swick & Foti, LLC (KSF) is sniffing around Pinterest's officers and directors. This is no small fry since KSF is steered by none other than...

Continue Reading
Tenax Sued: Investors Face Class Action Over TNX-103

Updated Category News Views 133

What Tenax Investors Need to Know Alright, folks, time to pull up a chair and pay attention to what's brewing with Tenax Therapeutics—yeah, we're talking NASDAQ: TENX. The company's head is spinning as it's caught up in a securities class action lawsuit. What's the fuss? The fine print here accuses Tenax of misleading investors about the effectiveness of their product,...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 108

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 157

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading

Top 5 Most Recently Viewed Articles

Alex Bastian Named VP of Commercial Strategy at Memo Therapeutics

Updated Category News Views 287

Alex Bastian Appointed as VP of Commercial Strategy at Memo Therapeutics AG Memo Therapeutics AG (or “MTx”), a late-stage biotech firm committed to transforming unique human immune responses into effective treatments for viral infections and cancer, has announced the appointment of Alex Bastian as its new VP of Commercial Strategy. Expertise in the Biotech Industry...

Continue Reading
AST SpaceMobile Partners with SDA to Advance Space Technology

Updated Category News Views 241

AST SpaceMobile's New Partnership with the Space Development Agency AST SpaceMobile, Inc. (NASDAQ: ASTS), a pioneering company in the development of the world's first space-based cellular broadband network, has made a significant stride by securing an initial contract with the Space Development Agency (SDA). This selection as a prime contractor represents a substantial...

Continue Reading
CIP Chemicals Market Set to Reach $3.69 Billion by 2029

Updated Category News Views 134

Exploring the Growth of the CIP Chemicals Market The CIP Chemicals Market is on an exciting trajectory, with projections indicating remarkable growth in the coming years. Analysts anticipate that the market will expand from USD 2.40 billion in 2024 to an impressive USD 3.69 billion by the year 2029. This growth signals a compound annual growth rate (CAGR) of 9.0%,...

Continue Reading
Rocket Lab Expands Partnership with iQPS for Future Missions

Updated Category News Views 217

Rocket Lab Partners with iQPS for Key Missions Rocket Lab USA, Inc. (Nasdaq: RKLB) has announced a significant contract with Institute for Q-shu Pioneers of Space, Inc. (iQPS), further solidifying its position as a leading provider of satellite launches. This new agreement includes three dedicated Electron missions, which will begin launching as early as 2026 from Rocket...

Continue Reading
Vinpai's Revenue and Growth Strategy: A 2024 Review

Updated Category News Views 111

Vinpai dropped its half-year numbers for 2024, and let me tell ya, it’s a mixed bag of good and bad. Sure, they reported a nice jump in sales—28% year-over-year to €5,111k—but you gotta dig deeper to see the cracks forming underneath that shiny surface. Revenue Growth vs. Margin Squeeze: What's the Real Deal? The revenue growth? That’s the feel-good story...

Continue Reading